Tags
Company, DePuy, Food and Drug Administration, Hip Replacement, Johnson, Stapler, Surgical staple, surgical staplers, Synthes
JNJ’s Medical Devices Business Faces Another Recall With Stapler — Trefis.
Johnson & Johnson (NYSE:JNJ) and recalls have started to seem like synonyms as the company is hit with another recall relating to its surgical stapler devices, which could pose serious health issues for patients. The company will recall as much as 157,000 stapler devices after the U.S. FDA tagged the recall as class I, the most serious.
The recall comes barely within two months of recent recall of the company’s Hemostatic Bone Putty, and may not bode well for the company, which is grappling to revive its Medical Devices & Diagnostics division.
The company’s brand value took a hit following the DePuy metal hip implants recall and related lawsuits. With its $21 billion Synthes aquisition, Johnson & Johnson is hoping to recover from these setbacks.
For the full article – click here.
Related articles
- Johnson and Johnson Still Not Out of the Recall Business – Surgical Staplers from Ethicon Division And Has Also Stopped Selling One of the Products (ducknetweb.blogspot.com)
- Plaintiffs look to depose new Johnson & Johnson CEO Gorsky in DePuy ASR lawsuit | MassDevice – Medical Device Industry News (earlsview.com)
- Johnson & Johnson’s Mishaps Mask A Great Business At A Reasonable Price (seekingalpha.com)
- US Drug Watchdog Now Urges All Recipients of a Recalled DePuy ASR Hip Implant to Call Them for the Names of the Best Possible Law Firms before the Deadline Comes & Goes (prweb.com)
- J&J’s $74 Value Hinges On Medical Devices Growth And Pharma Pipeline (forbes.com)
- US Drug Watchdog Now Urges All DePuy ASR And DePuy Pinnacle Hip Implant Recipients To Call Them For The Names Of The Best Law Firms Before Time Runs Out To Get Identified (prweb.com)
- Johnson & Johnson’s Q3 Earnings: What We Are Watching (forbes.com)
- US Drug Watchdog Now Urges All Recipients Of A Recalled DePuy ASR Hip Implant To Call Them For The Names Of The Best Possible Law Firms Before Time Runs Out (prweb.com)
- Media Digest (10/29/2012) Reuters, WSJ, NYT, FT, Bloomberg (dailyfinance.com)
- Media Digest (10/29/2012) Reuters, WSJ, NYT, FT, Bloomberg (247wallst.com)
Earl's View 
Earl, I just want to congratulate you on the gold that is “Recals-R-Us”, gotta admit I nearly had a bodily function accident laughing at that one!! Remember my hip brother, it is either laugh or cry!! But as always it couldn’t happen to a nicer company! I just can’t wait until Smith and Nephew and Others are up there with them!! It is coming!! Hope all of the hip Brothers and Sisters have had a good weekend under their individual experiences and look forward to a big information week! Cheers, Stu
Yes – you have to laugh or you will cry and J&J does seem to have the market cornered on recalls at the moment. One of the prices you pay for being the biggest and not having your shit together internally – huge brand damage from small things as well as big things – i.e. DePuy!
Earl